comparemela.com
  1. Home
  2. Live Updates
  3. Harish Shantharam - Breaking News

Latest Breaking News On - Harish shantharam - Page 1 : comparemela.com

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q3 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s Third Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.

CaliforniaUnited statesFloridaBostonMassachusettsAmericaChuck mcwherterLewis stuartGideon hirschfieldYasmeen rahimiRaymond jamesPiper sandlerSteven seedhouseRichard pratleyPaul quinlanHarish shantharam

Why Shares of CymaBay Therapeutics Are Soaring Friday

A competitor's drug had a so-so phase 3 trial, lifting the possibilities for CymaBay's lead therapy.

JapanRaymond jamesHarish shantharamSteven seedhouseEd arceHc wainwright coDrug administrationCymabay therapeuticsKaken pharmaceutical

Why CymaBay Therapeutics Stock Nose-Dived This Week

Investors did not warmly greet the latest news from the biotech.

Harish shantharamGilead sciencesCymabay therapeutics

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q1 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s First Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.

TorontoOntarioCanadaViennaWienAustriaZurichZüszSwitzerlandSujal shahKristen kluskaHarish shantharamJay olsonAndy hsiehPatrick dolezalLewis stuart

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.